91 related articles for article (PubMed ID: 22858179)
21. Vulnerability of peripheral catecholaminergic neurons to MPTP is not regulated by alpha-synuclein.
Cano-Jaimez M; Pérez-Sánchez F; Milán M; Buendía P; Ambrosio S; Fariñas I
Neurobiol Dis; 2010 Apr; 38(1):92-103. PubMed ID: 20079841
[TBL] [Abstract][Full Text] [Related]
22. Reduced striatal tyrosine hydroxylase in incidental Lewy body disease.
Beach TG; Adler CH; Sue LI; Peirce JB; Bachalakuri J; Dalsing-Hernandez JE; Lue LF; Caviness JN; Connor DJ; Sabbagh MN; Walker DG
Acta Neuropathol; 2008 Apr; 115(4):445-51. PubMed ID: 17985144
[TBL] [Abstract][Full Text] [Related]
23. alpha-Synuclein pathology in the spinal cord autonomic nuclei associates with alpha-synuclein pathology in the brain: a population-based Vantaa 85+ study.
Oinas M; Paetau A; Myllykangas L; Notkola IL; Kalimo H; Polvikoski T
Acta Neuropathol; 2010 Jun; 119(6):715-22. PubMed ID: 20037761
[TBL] [Abstract][Full Text] [Related]
24. Incidental Lewy body disease and preclinical Parkinson disease.
DelleDonne A; Klos KJ; Fujishiro H; Ahmed Z; Parisi JE; Josephs KA; Frigerio R; Burnett M; Wszolek ZK; Uitti RJ; Ahlskog JE; Dickson DW
Arch Neurol; 2008 Aug; 65(8):1074-80. PubMed ID: 18695057
[TBL] [Abstract][Full Text] [Related]
25. Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease.
Orimo S; Takahashi A; Uchihara T; Mori F; Kakita A; Wakabayashi K; Takahashi H
Brain Pathol; 2007 Jan; 17(1):24-30. PubMed ID: 17493034
[TBL] [Abstract][Full Text] [Related]
26. Selective detection, quantification, and subcellular location of alpha-synuclein aggregates with a protein aggregate filtration assay.
Kramer ML; Behrens C; Schulz-Schaeffer WJ
Biotechniques; 2008 Mar; 44(3):403-11. PubMed ID: 18361794
[TBL] [Abstract][Full Text] [Related]
27. Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies.
Klucken J; Ingelsson M; Shin Y; Irizarry MC; Hedley-Whyte ET; Frosch M; Growdon J; McLean P; Hyman BT
Acta Neuropathol; 2006 Feb; 111(2):101-8. PubMed ID: 16482476
[TBL] [Abstract][Full Text] [Related]
28. A critical reappraisal of current staging of Lewy-related pathology in human brain.
Jellinger KA
Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254
[TBL] [Abstract][Full Text] [Related]
29. Occurrence of alpha-synuclein pathology in the cerebellum of Guamanian patients with parkinsonism-dementia complex.
Sebeo J; Hof PR; Perl DP
Acta Neuropathol; 2004 Jun; 107(6):497-503. PubMed ID: 15024581
[TBL] [Abstract][Full Text] [Related]
30. Pathological correlates of gastrointestinal dysfunction in Parkinson's disease.
Cersosimo MG; Benarroch EE
Neurobiol Dis; 2012 Jun; 46(3):559-64. PubMed ID: 22048068
[TBL] [Abstract][Full Text] [Related]
31. α-Synuclein mRNA and soluble α-synuclein protein levels in post-mortem brain from patients with Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease.
Quinn JG; Coulson DT; Brockbank S; Beyer N; Ravid R; Hellemans J; Irvine GB; Johnston JA
Brain Res; 2012 Jun; 1459():71-80. PubMed ID: 22560502
[TBL] [Abstract][Full Text] [Related]
32. Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies with reference to striatal pathology.
Tsuboi Y; Uchikado H; Dickson DW
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S221-4. PubMed ID: 18267239
[TBL] [Abstract][Full Text] [Related]
33. Tuft-shaped astrocytes in Lewy body disease.
Hishikawa N; Hashizume Y; Yoshida M; Niwa J; Tanaka F; Sobue G
Acta Neuropathol; 2005 Apr; 109(4):373-80. PubMed ID: 15668789
[TBL] [Abstract][Full Text] [Related]
34. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease.
Shannon KM; Keshavarzian A; Mutlu E; Dodiya HB; Daian D; Jaglin JA; Kordower JH
Mov Disord; 2012 May; 27(6):709-15. PubMed ID: 21766334
[TBL] [Abstract][Full Text] [Related]
35. Analysis of colonic alpha-synuclein pathology in multiple system atrophy.
Pouclet H; Lebouvier T; Coron E; Rouaud T; Flamant M; Toulgoat F; Roy M; Vavasseur F; Bruley des Varannes S; Neunlist M; Derkinderen P
Parkinsonism Relat Disord; 2012 Aug; 18(7):893-5. PubMed ID: 22560049
[TBL] [Abstract][Full Text] [Related]
36. Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts.
Jellinger KA
Mov Disord; 2012 Jan; 27(1):8-30. PubMed ID: 22081500
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylated α-synuclein immunoreactivity in the posterior pituitary lobe.
Homma T; Mochizuki Y; Mizutani T
Neuropathology; 2012 Aug; 32(4):385-9. PubMed ID: 22082318
[TBL] [Abstract][Full Text] [Related]
38. Early alpha-synuclein lipoxidation in neocortex in Lewy body diseases.
Dalfó E; Ferrer I
Neurobiol Aging; 2008 Mar; 29(3):408-17. PubMed ID: 17166629
[TBL] [Abstract][Full Text] [Related]
39. Intralaminar nuclei of the thalamus in Lewy body diseases.
Brooks D; Halliday GM
Brain Res Bull; 2009 Feb; 78(2-3):97-104. PubMed ID: 18804518
[TBL] [Abstract][Full Text] [Related]
40. [Autonomic nervous system as a source of biomarkers in Parkinson's disease].
Pouclet H; Lebouvier T; Flamant M; Coron E; Neunlist M; Derkinderen P; Rouaud T
Presse Med; 2012 Jul; 41(7-8):695-701. PubMed ID: 22284542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]